Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:A7KAX9 (
grit
)
1,275
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mecp2 is a DNA methylation reader that plays a critical role in experience-dependent plasticity. Increasing evidence supports a role for epigenetic modifications in activity-induced gene expression. Hence, candidate genes related to such phenomena are of great interest. Ryanodine receptors are intracellular calcium channels that contribute to hippocampal synaptic plasticity, dendritic spine remodeling, and participate in learning and memory processes. Here we exposed mice to the enriched environment (EE) paradigm, which through increased stimulation induces experience dependent-plasticity, to explore a role for methyl-cytosines, and Mecp2 in directing Ryanodine receptor 3 (
Ryr3
) transcriptional activity. EE induced a hippocampal-specific increase in the methylation of discrete cytosines located at a
Ryr3
isoform promoter; chromatin immunoprecipitation experiments revealed that EE increased Mecp2 binding to this
Ryr3
isoform promoter. Interestingly, the experimental paradigm induced robust
Ryr3
upregulation, accompanied by
miR132
-dependent suppression of
p250GAP
, a pathway driving synaptogenesis. In contrast to WT mice,
Mecp2-null
mice showed diminished levels of
Ryr3
and displayed impaired EE-induced
Ryr3
upregulation, compromising
miR132
dependent suppression of
p250GAP
and experience-dependent structural plasticity. Based on these results, we propose that Mecp2 acts as a
transcriptional activator
of
Ryr3
, contributing to experience-dependent plasticity.
...
PMID:Mecp2 Mediates Experience-Dependent Transcriptional Upregulation of Ryanodine Receptor Type-3. 2865 60